Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy

NCT04068896

Conditions
Adnexal Diseases, Bladder Cancer, Bronchial Neoplasms, +69 more
Locations
  • NGM Clinical Study Site Tucson, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sacramento, California, United States
View all 20 locations
View Trial Details
Completed

Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

NCT04337970

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Completed

A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors

NCT02799095

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +34 more
Locations
  • Mural Oncology Investigational Site Denver, Colorado, United States
  • Mural Oncology Investigational Site Port Saint Lucie, Florida, United States
  • Mural Oncology Investigational Site Tampa, Florida, United States
  • Mural Oncology Investigational Site Lexington, Kentucky, United States
View all 31 locations
View Trial Details
Completed

Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

NCT04040231

Conditions
Adenoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +26 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies

NCT04383938

Conditions
Advanced Solid Tumor, Bladder Cancer, Bronchial Neoplasms, +32 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Center Boston, Massachusetts, United States
View Trial Details

Related conditions